BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38225622)

  • 21. Giant congenital melanocytic nevi: the significance of neurocutaneous melanosis in neurologically asymptomatic children.
    Foster RD; Williams ML; Barkovich AJ; Hoffman WY; Mathes SJ; Frieden IJ
    Plast Reconstr Surg; 2001 Apr; 107(4):933-41. PubMed ID: 11252085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurocutaneous melanocytosis-associated malignant melanoma presenting with peritoneal seeding.
    Sener U; Elmore K; Jayaseelan K; Porter J; Marghoob A; Rosenblum MK; Haque S; Khakoo Y
    Pediatr Dermatol; 2021 Sep; 38(5):1298-1301. PubMed ID: 34463389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway.
    Basu D; Salgado CM; Bauer BS; Johnson D; Rundell V; Nikiforova M; Khakoo Y; Gunwaldt LJ; Panigrahy A; Reyes-Múgica M
    Neuro Oncol; 2016 Apr; 18(4):528-37. PubMed ID: 26354928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal leptomeningeal melanoma in neurocutaneous melanosis.
    Furtado S; Furtado SV; Ghosal N; Hegde AS
    Pediatr Dermatol; 2012; 29(3):358-61. PubMed ID: 21906139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copy number variations as potential diagnostic and prognostic markers for CNS melanocytic neoplasms in neurocutaneous melanosis.
    van Engen-van Grunsven AC; Rabold K; Küsters-Vandevelde HV; Rijntjes J; Djafarihamedani M; Hehir-Kwa JY; Küsters B; Willemsen MA; van der Burgt I; Wesseling P; Blokx WA; Groenen PJ
    Acta Neuropathol; 2017 Feb; 133(2):333-335. PubMed ID: 27988846
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of positron emission tomography in the management of neurocutaneous melanocytosis.
    Cabanillas M; Ginarte M; Monteagudo B; Toribio J
    Pediatr Dermatol; 2009; 26(3):351-2. PubMed ID: 19706106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid response to therapy of neurocutaneous melanosis with leptomeningeal melanoma.
    Subbiah V; Wolff JE
    Pediatr Blood Cancer; 2010 Jan; 54(1):180-1. PubMed ID: 19722276
    [No Abstract]   [Full Text] [Related]  

  • 28. Sudden change of a large congenital melanocytic nevus to neurocutaneous melanosis.
    Lee CJ; Park JH; Lee SI
    J Craniofac Surg; 2006 Nov; 17(6):1216-8. PubMed ID: 17119434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Melanocytic Tumors].
    Okamoto K; Natsumeda M; Oishi M; Fujii Y
    No Shinkei Geka; 2021 Mar; 49(2):389-394. PubMed ID: 33762462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocutaneous melanosis.
    Islam MP
    Handb Clin Neurol; 2015; 132():111-7. PubMed ID: 26564074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurocutaneous Melanosis in Association With Large Congenital Melanocytic Nevi in Children: A Report of 2 Cases With Clinical, Radiological, and Pathogenetic Evaluation.
    Chen L; Zhai L; Al-Kzayer LFY; Sarsam SN; Liu T; Alzakar RH; Nakazawa Y
    Front Neurol; 2019; 10():79. PubMed ID: 30792691
    [No Abstract]   [Full Text] [Related]  

  • 32. Intramedullary and retroperitoneal melanocytic tumor associated with congenital blue nevus and nevus flammeus: an uncommon combination of neurocutaneous melanosis and phacomatosis pigmentovascularis--case report.
    Kurokawa R; Kim P; Kawamoto T; Matsuda H; Hayashi S; Yamazaki S; Hatamochi A; Mori S; Shimoda M; Kubota K
    Neurol Med Chir (Tokyo); 2013; 53(10):730-4. PubMed ID: 24077274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal GNAQ-mutated CNS melanoma in an adolescent with nevus of Ota.
    Blundell AR; Moustafa D; Samore WR; Hawryluk EB
    Pediatr Dermatol; 2021 Mar; 38(2):497-499. PubMed ID: 33421174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary leptomeningeal melanoma in association with neurocutaneous melanosis: A case report.
    Qazi SS; Shah SMI; Baqai MWS; Enam SA
    Surg Neurol Int; 2022; 13():547. PubMed ID: 36600756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?
    Patel J; Salgado CM; Múgica MR; Basu D
    Neuro Oncol; 2016 Jan; 18(1):142-3. PubMed ID: 26667139
    [No Abstract]   [Full Text] [Related]  

  • 36. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
    Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
    Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to "Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?".
    Ruan Y; Narendran A
    Neuro Oncol; 2016 Jan; 18(1):143-4. PubMed ID: 26667140
    [No Abstract]   [Full Text] [Related]  

  • 38. Neurocutaneous melanosis with an intracranial cystic-solid meningeal melanoma in an adult: A case report and review of literature.
    Liu BC; Wang YB; Liu Z; Jiao Y; Zhang XF
    World J Clin Cases; 2022 May; 10(15):5025-5035. PubMed ID: 35801056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSF cytology diagnosis of NRAS-mutated primary leptomeningeal melanomatosis with neurocutaneous melanosis.
    Kolin DL; Geddie WR; Ko HM
    Cytopathology; 2017 Jun; 28(3):235-238. PubMed ID: 27696542
    [No Abstract]   [Full Text] [Related]  

  • 40. Leptomeningeal melanomatosis associated with neurocutaneous melanosis: an autopsy case report.
    Matsumura M; Okudela K; Tateishi Y; Umeda S; Mitsui H; Suzuki T; Nakayama T; Inayama Y; Ohashi K
    Pathol Int; 2015 Feb; 65(2):100-5. PubMed ID: 25521302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.